ArticleFrontiers in oncology2025

Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC.

Xinhang Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.